NYSE: AGL · Industrial Applications and Services · 3 alerts · CIK 1831097
Share price
$116.75Close, Nov 16
Market cap
$1.96B
Shares outstanding
16.8MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Services-Misc Health & Allied Services, NECSIC 8090
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All agilon health, inc. filings on SEC EDGAR ↗
agilon health, inc. is hosting a virtual investor event on November 17, 2026, to present its strategic framework for driving performance at scale. The company filed a formal investor presentation deck as an exhibit, which includes discussions on its technology-enabled clinical programs and long-term growth trajectory.
agilon health, inc. reported a significant financial turnaround for the nine months ended September 30, 2026, achieving a net income of $101.8 million compared to a net loss of $202.5 million in the prior year period. This improvement was driven by a reduction in medical services expenses and a $19.0 million gain from discontinued operations.
agilon health reported third quarter 2026 revenue of $1.52 billion, a 6% increase year-over-year, and a net income of $35 million compared to a net loss in the prior year. The company raised its full-year 2026 guidance for revenue and Adjusted EBITDA following stronger-than-expected performance in burden of illness and payor contracting.
“agilon’s third quarter results exceeded our expectations, reflecting the disciplined execution and operational progress our team has delivered this year. Central to that progress is our proximity to physicians and their patients, which differentiates our model and enables us to pair trusted relationships with actionable insights that help deliver better outcomes at the point of care.”
Tim O’Rourke, Chief Executive Officer of agilon health